IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 167 filers reported holding IMMUNOMEDICS INC in Q4 2017. The put-call ratio across all filers is 0.49 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $480,000 | +31.5% | 25,000 | 0.0% | 0.03% | +57.9% |
Q1 2018 | $365,000 | -67.8% | 25,000 | -64.3% | 0.02% | -63.5% |
Q4 2017 | $1,132,000 | +101.4% | 70,000 | -49.4% | 0.05% | +372.7% |
Q2 2015 | $562,000 | -57.6% | 138,400 | -60.0% | 0.01% | -59.3% |
Q1 2015 | $1,325,000 | – | 346,090 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Avoro Capital Advisors LLC | 10,488,076 | $92,610,000 | 11.69% |
First Light Asset Management, LLC | 2,048,643 | $18,090,000 | 6.07% |
Foresite Capital Management III, LLC | 1,940,850 | $17,138,000 | 5.60% |
DAFNA Capital Management LLC | 637,700 | $5,631,000 | 4.02% |
ACUTA CAPITAL PARTNERS, LLC | 1,600,000 | $14,128,000 | 3.95% |
Opaleye Management Inc. | 900,000 | $7,947,000 | 3.32% |
Ghost Tree Capital, LLC | 1,200,000 | $10,596,000 | 2.20% |
Iguana Healthcare Management, LLC | 325,000 | $2,870,000 | 1.62% |
Healthcare Value Capital, LLC | 100,000 | $883,000 | 1.59% |
Palo Alto Investors LP | 3,010,466 | $26,582,000 | 1.24% |